“Dupilumab-Treated Patients With Prurigo Nodularis Report Disease Control and Treatment Satisfaction: 6-Month Results From the RELIEVE-PN Study” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s716. doi:10.25251/h522p595.